Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 738

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 738
---
30, 2024 and 2023 | ​ | ​ | ​    | ​ | F-117 | ​ | ​ |
| Unaudited condensed statements of cash flows for the nine months ended September 30, 2024 and2023                                                        | ​ | ​ | ​    | ​ | F-118 | ​ | ​ |
| Notes to unaudited condensed financial statements                                                                                                        | ​ | ​ | ​    | ​ | F-119 | ​ | ​ |

F-1

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands, excluding share and per share data)
(unaudited)

| ​                                                                                                                                                                                                                                                                  
 Assets                                                                                                                                                                                                                                                             
 Current assets:                                                                                                                                                                                                                                                    | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | September 30,2024 
 ​                 
 ​                 | ​ 
 ​ |        ​ 
        ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | December 31,2023 
 ​                
 ​                | ​ 
 ​ |        ​ 
        ​ | ​ 
 ​ | ​ 
 ​ 
 ​ |
|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|:--|:------------------|:--|---------:|:--|:--|:--|:-----------------|:--|---------:|:--|:--|
| Cash and cash equivalents                                                                                                                                                                                                                                          | ​ | ​ | ​                 | $ |   37,061 | ​ | ​ | ​ | ​                | $ |   51,775 | ​ | ​ |
| Marketable securities                                                                                                                                                                                                                                              | ​ | ​ | ​                 | ​ |    4,975 | ​ | ​ | ​ | ​                | ​ |   48,983 | ​ | ​ |
| Accounts receivable, net – related party                                                                                                                                                                                                                           | ​ | ​ | ​                 | ​ |      435 | ​ | ​ | ​ | ​                | ​ |    2,765 | ​ | ​ |
| Inventory, net                                                                                                                                                                                                                                                     | ​ | ​ | ​                 | ​ |      625 | ​ | ​ | ​ | ​                | ​ |    2,821 | ​ | ​ |
| Income tax receivable                                                                                                                                                                                                                                              | ​ | ​ | ​                 | ​ |        — | ​ | ​ | ​ | ​                | ​ |      697 | ​